BioAtla, Inc. (BCAB)
1.26
-0.06
(-4.55%)
USD |
OTCM |
Sep 08, 16:00
BioAtla Market Cap : 2.096M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.096M |
| September 04, 2026 | 2.196M |
| September 03, 2026 | 2.162M |
| September 02, 2026 | 2.004M |
| September 01, 2026 | 1.796M |
| August 31, 2026 | 2.811M |
| August 28, 2026 | 2.886M |
| August 27, 2026 | 5.223M |
| August 26, 2026 | 5.190M |
| August 25, 2026 | 5.422M |
| August 24, 2026 | 5.456M |
| August 21, 2026 | 5.289M |
| August 20, 2026 | 5.289M |
| August 19, 2026 | 5.439M |
| August 18, 2026 | 5.289M |
| August 17, 2026 | 5.090M |
| August 14, 2026 | 5.140M |
| August 13, 2026 | 5.738M |
| August 12, 2026 | 5.622M |
| August 11, 2026 | 5.822M |
| August 10, 2026 | 5.759M |
| August 07, 2026 | 5.742M |
| August 06, 2026 | 5.526M |
| August 05, 2026 | 5.518M |
| August 04, 2026 | 5.560M |
| Date | Value |
|---|---|
| August 03, 2026 | 5.410M |
| July 31, 2026 | 5.460M |
| July 30, 2026 | 5.609M |
| July 29, 2026 | 5.344M |
| July 28, 2026 | 5.858M |
| July 27, 2026 | 5.643M |
| July 24, 2026 | 5.593M |
| July 23, 2026 | 5.742M |
| July 22, 2026 | 5.626M |
| July 21, 2026 | 6.124M |
| July 20, 2026 | 6.140M |
| July 17, 2026 | 6.555M |
| July 16, 2026 | 6.622M |
| July 15, 2026 | 7.070M |
| July 14, 2026 | 6.738M |
| July 13, 2026 | 6.489M |
| July 10, 2026 | 6.340M |
| July 09, 2026 | 6.174M |
| July 08, 2026 | 5.958M |
| July 07, 2026 | 6.771M |
| July 06, 2026 | 7.601M |
| July 02, 2026 | 6.954M |
| July 01, 2026 | 6.780M |
| June 30, 2026 | 6.871M |
| June 29, 2026 | 6.356M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.67B |
| Oncolytics Biotech, Inc. | 99.62M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.324B |
| Anixa Biosciences, Inc. | 96.34M |
Market Cap Related Metrics
| PS Ratio | 7.237 |
| Price | 1.26 |
| Earnings Yield | -19.42% |